Reselute Medical develops therapeutic implant technologies for fracture management, specifically targeting orthopedic-related infections. Its primary product, the investigational Reselution Tibial Intramedullary Fixation System, combines structural bone fixation with sustained local antibiotic delivery in a single procedure for patients with severe fractures.
Subscribe to see Reselute, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Reselute, Inc. is a therapeutic devices company headquartered in United States. It has raised at least $6.1M across the 4 funding rounds on record. Its most recent funding round raised $1M in July 2026. Xcout tracks 6 named people at Reselute, Inc., including Cambre Kelly (President and CEO).
At least $6.1M raised across the 4 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $1M | — | |
| SEC Form D filing | $1.8M | — | |
| SEC Form D filing | $2.6M | — | |
| SEC Form D filing | $700,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Reselute, Inc.'s closest competitors — see the full list of competitors and alternatives →
Purgo Scientific is a medical device company that develops localized, sustained drug delivery devices designed to treat orthopedic biofilm infections and fracture-related infections. Their lead preclinical product, the Purgo Pouch, is a combination product intended to sustain local antibiotic therapy, kill biofilms, and expedite wound healing.
Axia Orthopedics develops medical devices for orthopedic fracture fixation, specifically offering the SOLOFIX Wire Lock system to simplify provisional fixation and bone fragment compression. The company serves orthopedic surgeons and trauma specialists by providing less invasive surgical tools that improve workflow and reduction efficiency.
IlluminOss Medical is a commercial-stage medical device company that develops minimally invasive, photodynamic bone stabilization systems for fracture treatment.
RevOrtho LLC develops advanced orthopedic technology and medical devices focused on bone and tissue preservation. The company designs specialized systems for orthopedic surgeons and patients, including modular hip resurfacing and patellofemoral resurfacing arthroplasty products.
Garwood Medical Devices, LLC develops technologies aimed at addressing bacterial biofilm infections related to medical implants. Their primary product under investigation is BioPrax, which is designed to help patients retain implants and improve infection control.
Heraeus Medical develops and manufactures medical solutions for surgical orthopaedics and trauma surgery, including bone cements for implant fixation, products for musculoskeletal infection management, and resorbable biomaterials for bone regeneration. The company serves healthcare professionals and patients globally by providing products designed to restore patient mobility.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.